Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery | News
Search Refinements

Drug Delivery News

View news from other Pharmaceutical sectors:
151-165 of 2298 results
Synairgen unveils positive results from ongoing collaboration with Pharmaxis
Synairgen announced positive results from its ongoing collaboration with Pharmaxis (ASX: PXS) to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as a novel treatment for the fatal lung disease idiopathic pulmonary fibrosis (IPF).
Drug Research > Drug Delivery > News
Evotec spins off auto-immune disease company as Topas Therapeutics
Evotec announced the formation of a spin-off company in the field of nanoparticle-based therapeutics to treat immunological disorders.
Drug Research > Drug Delivery > News
LEO Pharma gets scientific approval of Enstilar to treat Psoriasis in EU
LEO Pharma has received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Drug Research > Drug Delivery > News
PixarBio unveils USFDA OPD submission of NR-SCI for orphan drug designation for spinal cord injury
PixarBio has filed an application with the US FDA Office of Orphan Products Development, for orphan drug status of its NeuroRelease SCI (NR-SCI) a novel drug candidate for the treatment of Spinal Cord Injury (SCI).
Drug Research > Drug Delivery > News
New Cancer Drugs Fund provides faster access to effective cancer treatments
New arrangements for the Cancer Drugs Fund (CDF), approved today by NICE’s Board, will see patients benefitting as promising new and innovative treatments are considered earlier.
Drug Research > Drug Delivery > News
Repros activates process for securing marketing authorization for enclomiphene
Repros Therapeutics has formally activated the process for obtaining marketing authorization for enclomiphene in the treatment of secondary hypogonadism by the European Medicines Agency (EMA).
Drug Research > Drug Delivery > News
EMA reviews cancer medicine Zydelig
The European Medicines Agency (EMA) has, at the request of the European Commission, started a review of the cancer medicine Zydelig (idelalisib), which is authorised in the EU to treat two types of rare blood cancers called chronic lymphocytic leukaemia and follicular lymphoma (one of a group of cancers called non-Hodgkin lymphoma).
Drug Research > Drug Delivery > News
FDA accepts Aeglea's IND application for AEB1102 to treat hematological malignancies
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted Aeglea BioTherapeutics' investigational new drug (IND) application for AEB1102 to treat patients with hematological malignancies.
Drug Research > Drug Delivery > News
Actinium Pharmaceuticals starts pursuit of EU Orphan Designation for Iomab-B
Actinium Pharmaceuticals has engaged a leading European-based regulatory affairs consulting firm to pursue orphan medicines designation by the European Medicines Agency (EMA) for Iomab-B.
Drug Research > Drug Delivery > News
Grindeks says Meldonium should not be included in prohibited list
By PBR Staff Writer
Latvian pharmaceutical firm Grindeks said meldonium should not be included in the prohibited list after tennis star Maria Sharapova tested positive for the drug.
Drug Research > Drug Delivery > News
XBiotech submits MAA for candidate colorectal cancer therapy to European Medicines Agency
XBiotech has submitted its Marketing Authorization Application (MAA) for its candidate therapy (Xilonix) for advanced colorectal cancer to the European Medicines Agency (EMA).
Drug Research > Drug Delivery > News
GSK asthma drug Nucala's Cosmos study demonstrates safety profile
By PBR Staff Writer
GlaxoSmithKline (GSK) said its asthma drug, Nucala, demonstrated a similar safety profile in a long-term study compared with previous trials.
Drug Research > Drug Delivery > News
Vaxart starts preclinical testing of oral Zika virus vaccine
Vaxart has initiated preclinical testing of an oral vaccine for Zika virus.
Drug Research > Drug Delivery > News
Clinigen acquires US-approved Totect from Biocodex
Clinigen Group has acquired Totect (dexrazoxane) from Biocodex USA, a product that is patent protected in US, Canada and Mexico.
Drug Research > Drug Delivery > News
McKesson to buy Canadian drug store chain Rexall Health for $2.2bn
By PBR Staff Writer
McKesson has agreed to acquire Canadian pharmacy drug store chain Rexall Health from Katz Group for C$3bn ($2.2bn).
Drug Research > Drug Delivery > News
151-165 of 2298 results